Oncology and Hematology

Episodes 177-192 of 386

Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Project Oncology®
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
- Munir Ghesani, MD
Enhancing HCC Outcomes Through Multidisciplinary Care
Enhancing HCC Outcomes Through Multidisciplinary Care
Project Oncology®
Enhancing HCC Outcomes Through Multidisciplinary Care
- Charles Turck, PharmD, BCPS, BCCCP
- Hannah Lee, MD
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Project Oncology®
Optimizing HCC Screening: Strategies to Overcome Common Barriers
- Hannah Lee, MD
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
CME/CE
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
0.25 credits
- Jennifer Caudle, DO
- Patricia A. Mangan, RN, MSN, APRN-BC
0.25 credits
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
Project Oncology®
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
- Jody Takemoto, PhD
- Robert Wong, MD
Key Highlights from SNMMI 2024
Key Highlights from SNMMI 2024
Project Oncology®
Key Highlights from SNMMI 2024
An Overview of the Fundamentals of PET-CT Imaging
An Overview of the Fundamentals of PET-CT Imaging
Project Oncology®
An Overview of the Fundamentals of PET-CT Imaging
An Exploration of Multiple Myeloma Treatments
An Exploration of Multiple Myeloma Treatments
Project Oncology®
An Exploration of Multiple Myeloma Treatments
Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Multiple Myeloma
Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Multiple Myeloma
Project Oncology®
Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Multiple Myeloma
- Jesus G. Berdeja, MD
- Nicholas G. Barkemeyer, MPAS
- Ajai Chari, MD
- Harvey Church
- Amy Gebhardt
- Steven Morrow
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
Project Oncology®
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
- Matt Birnholz, MD
- Saad Kenderian M.B, Ch.B
Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection
Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection
Project Oncology®
Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection
- Jody Takemoto, PhD
- Robert Wong, MD
Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis
Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis
Project Oncology®
Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis
- Jody Takemoto, PhD
- Robert Wong, MD
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
CME/CE Broadcast Replay
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
1.00 credit
- Jennifer Caudle, DO
- Patricia A. Mangan, RN, MSN, APRN-BC
1.00 credit
A Look at the Utility of PSMA PET Scans in Prostate Cancer
A Look at the Utility of PSMA PET Scans in Prostate Cancer
Project Oncology®
A Look at the Utility of PSMA PET Scans in Prostate Cancer
- Jennifer Caudle, DO
- Geoffrey B. Johnson, M.D., Ph.D.
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
Project Oncology®
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
- Geoffrey B. Johnson, M.D., Ph.D.
Highlighting the Current Status and Future of Theranostics
Highlighting the Current Status and Future of Theranostics
Project Oncology®
Highlighting the Current Status and Future of Theranostics
- Geoffrey B. Johnson, M.D., Ph.D.